Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

AURLUMYN

ILOPROST

Standard Dose
100MCG/ML (100MCG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview AURLUMYN is listed in Drugs@FDA under application 217933 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ILOPROST Form and strength SOLUTION;INTRAVENOUS - 100MCG/ML (100MCG/ML) Sponsor BTG INTL Submission history Latest submission status date: 2024-05-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview AURLUMYN is listed in Drugs@FDA under application 217933 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ILOPROST Form and strength SOLUTION;INTRAVENOUS - 100MCG/ML (100MCG/ML) Sponsor BTG INTL Submission history Latest submission status date: 2024-05-14 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.